Viewing nowAtorvaspo 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.

MFDS item code 201403318 · Approved 2014.07.23 · Insurance code 654701510
Improvement of hyperlipidemia (including pediatric familial hyperlipidemia, etc.); prevention of cardiovascular diseases (including myocardial infarction, etc.)
This medication helps reduce the risk of cardiovascular diseases. It particularly lowers the risk of myocardial infarction, stroke, vascular surgeries, and angina, and also prevents hospitalization due to congestive heart failure. It lowers total cholesterol and LDL-cholesterol levels in patients with hyperlipidemia and increases HDL-cholesterol levels, thereby improving blood lipid conditions. In pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia, this medication can be used along with dietary measures to reduce the risk of cardiovascular diseases. Overall, it is effective in improving cardiovascular health.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily, but patients requiring greater reductions in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia: This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are not available. Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is required. Elderly patients: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult population.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication may cause serious side effects related to muscles; therefore, if muscle pain or weakness symptoms occur, discontinue use immediately and consult a doctor. It should not be taken if there is a history of allergic reactions to this medication, liver disease, muscle disease, during pregnancy or breastfeeding. Patients with impaired liver function, alcoholics, the elderly, or those with impaired kidney function should use this medication cautiously, and regular examinations to confirm their condition are important. Since this medication is metabolized in the liver, its blood concentration may rise and increase the risk of side effects when taken with certain antibiotics, antifungals, antiviral medications, etc. Therefore, it's essential to inform your doctor or pharmacist about any currently taken medications. Women who are pregnant or may become pregnant should ensure appropriate contraception while taking this medication and must discontinue use if pregnancy is confirmed. Women who are breastfeeding should not take this medication and must avoid breastfeeding while on it. During the period of taking this medication, regular blood tests to monitor liver function and serum creatine kinase (CK) levels should be performed to monitor liver and muscle conditions. In case of overdose, as there are no specific antidotes, visit a medical facility immediately for proper treatment, and check for liver function and muscle damage based on symptoms. Keep this medication out of reach of children, and store it in its original container to maintain quality. Long-term use of this medication may slightly increase the risk of developing diabetes, so it is advisable to monitor blood sugar levels regularly. If symptoms such as muscle pain, weakness, fever, or fatigue occur, inform your doctor immediately and undergo examination. If symptoms are severe or CK levels are significantly elevated, discontinue use. Taking this medication with grapefruit juice may increase blood concentration, so it is advisable to avoid grapefruit juice.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering, and the storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication and prevent deterioration.
White circular film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.